|

Mesenchymal Stem Cell Clinical Trials

1 actively recruiting trial across 1 location

Also known as: MPC, Mesenchymal Progenitor Cell

Pipeline

Phase 1/2: 1

Top Sponsors

  • M.D. Anderson Cancer Center1

Indications

  • COVID-19-Associated Acute Respiratory Distress Syndrome1
  • Symptomatic COVID-19 Infection Laboratory-Confirmed1
  • COVID-19 Infection1
  • Hematopoietic and Lymphoid Cell Neoplasm1
  • Malignant Solid Neoplasm1

Houston, Texas1 trial

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

M D Anderson Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.